TITLE

PATTERNS OF GI DISEASE IN ADULTHOOD ASSOCIATED WITH MUTATIONS IN THE CFTR GENE

AUTHOR(S)
Wilschanski, Michael; Dune, Peter R.
PUB. DATE
August 2007
SOURCE
Gut;Aug2007, Vol. 56 Issue 8, p1153
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article examines the clinical manifestations of gastrointestinal disease in adults that are associated with mutations in the cystic fibrosis transmembrane regulator (CFTR) protein. It discusses the challenges of establishing or excluding a CF diagnosis in patients who are presented with de novo in childhood. It also gives an account of the emerging knowledge of the potential contribution of mutations in the CFTR gene to other complex genetic conditions.
ACCESSION #
25972147

 

Related Articles

  • The clinical and laboratory manifestations of Iranian patients with cystic fibrosis. Fallahi1, Gholamhossein; Najafi1, Mehri; Farhmand1, Fatemeh; Bazvand, Fatemeh; Ahmadi, Maedeh; Ahmadi, Faezeh; Eftekhari, Kambiz; Khodad, Ahmad // Turkish Journal of Pediatrics;Mar/Apr2010, Vol. 52 Issue 2, p132 

    Cystic fibrosis (CF) is a hereditary disease, characterized by chronic pulmonary disease, pancreatic insufficiency and abnormal electrolytes in the sweat. In order to evaluate the clinical manifestations and laboratory findings of Iranian children with CF during a 10-year period, 243 CF...

  • The PEST sequence does not contribute to the stability of the cystic fibrosis transmembrane conductance regulator. Chen, Eva Y.; Clarke, David M. // BMC Biochemistry;2002, Vol. 3, p29 

    Background: Endoplasmic reticulum retention of misfolded cystic fibrosis transmembrane conductance regulator (CFTR) mutants and their rapid degradation is the major cause of cystic fibrosis (CF). An important goal is to understand the mechanism of how the misfolded proteins are recognized,...

  • Turmeric for cystic fibrosis? SSC // Prevention;Dec2004, Vol. 56 Issue 12, p40 

    Reports that tumeric, a spice in curry powder, may offer new hope for people with cystic fibrosis. Function of defective proteins helped by turmeric.

  • Clinical features, pathogenesis,and management of meconium ileus equivalent. Weller, P. H.; William, J. // Journal of the Royal Society of Medicine (Supplement);Jan1986, Vol. 79 Issue 12, p36 

    The article focuses on the clinical features, pathogenesis and management of meconium ileus equivalent (MIE), the partial or complete intestinal obstruction occurring in patients with cystic fibrosis. MIE can present with abdominal pain and distension, vomiting and total constipation. It is also...

  • Method of Classifying Disease Severity May Help Streamline CF Research. Begany, Timothy // Pulmonary Reviews;Nov2006, Vol. 11 Issue 11, p20 

    The article discusses research being done on the significance of classifying disease severity to cystic fibrosis (CF) research. It references a study by M. D. Schluchter and colleagues, published in the 2006 issue of the "American Journal of Respiratory and Critical Care Medicine." It describes...

  • Nonsense mutations: Running the red light. Ainsworth, Claire // Nature;12/8/2005, Vol. 438 Issue 7069, p726 

    The article reports on the clinical trials conducted for PTC124 drug that can treat genetic diseases. The trial was conducted on patients in an Israeli hospital who hopes to cure their cystic fibrosis. PTC124 aims at thwarting a cellular process called nonsense-mediated decay. Research into this...

  • Fixing cystic fibrosis CFTR with correctors and potentiators. Off to a good start. Elborn, J. Stuart // Thorax;Jan2012, Vol. 67 Issue 1, p4 

    The author reflects on the results of several studies on treating cystic fibrosis (CF) with correctors and potentiators. He states that numerous in vitro and animal studies suggests that it is possible to correct the cystic fibrosis transmembrane regulator (CFTR) and will make a significant...

  • Guanylin in the human pancreas: a novel luminocrine regulatory pathway of electrolyte secretion via cGMP and CFTR in the ductal system. Kulaksiz, Hasan; Schmid, Andreas; Hönscheid, Matthias; Eissele, Rolf; Klempnauer, Jürgen; Cetin, Yalcin // Histochemistry & Cell Biology;Feb2001, Vol. 115 Issue 2, p131 

    The article focuses on a novel luminocrine regulatory pathway of electrolyte secretion via cGMP and cystic fibrosis transmembrane conductance regulator (CFTR) in the ductal system. The authors show that the peptide guanylin is a specific activator of CFTR function in the human pancreas...

  • New View of Cystic Fibrosis. Klotter, Jule // Townsend Letter for Doctors & Patients;Nov2005, Issue 268, p27 

    Reports on the results of a research conducted by Wake Forest Baptist Medical Center in Winston-Salem, North Carolina, on cystic fibrosis (CF). Discovery of the researchers that people with CF produce too little mucus; Comparison of the amounts of two proteins used to produce mucus between CF...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics